FDA takes first step in possible reversal of ban on some peptides The Washington Post BPC 157 and the Difference Between an Evidence Gap and a Cover Up: What the entire human evidence base actually looks like, and the questions to ask next. WellFounded Founders Health & The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York FDA Peptide Update: Category 2 Removals Explained FDA to weigh easing limits on unproven peptides favored by RFK Jr. and other MAHA figures The Washington Post